Last reviewed · How we verify
decompensated cirrhosis
Approved treatments
- Livdelzi · Gilead Sciences Inc
Livdelzi works by inhibiting the activity of a specific enzyme involved in the progression of liver disease. - Iqirvo · Ipsen
Iqirvo works by activating peroxisome proliferator-activated receptors to improve liver function.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- decompensated cirrhosis patent landscape — cliff calendar, originator estates, attackable patents
- decompensated cirrhosis treatment landscape brief
- decompensated cirrhosis treatment updates RSS
Frequently asked questions about decompensated cirrhosis
What drugs treat decompensated cirrhosis?
Tracked treatments include Livdelzi, Iqirvo.
What is the treatment for decompensated cirrhosis?
Standard treatment for decompensated cirrhosis includes Livdelzi, Iqirvo. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: decompensated cirrhosis patent cliff · decompensated cirrhosis CI report
- Treatment: Livdelzi · Gilead Sciences Inc
- Treatment: Iqirvo · Ipsen
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing